2012
DOI: 10.1002/bit.24611
|View full text |Cite
|
Sign up to set email alerts
|

Host cell protein quantification by fourier transform mid infrared spectroscopy (FT‐MIR)

Abstract: Process development in up- and downstream processing requires enhanced, non-time-consuming, and non-expensive monitoring techniques to track product purity, for example, the level of endotoxins, viral particles, and host cell proteins (HCPs). Currently, HCP amounts are measured by laborious and expensive HCP-enzyme-linked immunosorbent assay (ELISA) assays best suited for measuring HCP amounts in the low concentration regime. The measurement of higher HCP amounts using this method requires dilution steps, addi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
23
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 37 publications
(24 citation statements)
references
References 33 publications
0
23
0
Order By: Relevance
“…Potential risks associated with specific HPCs may include immunogenicity, adjuvant activity, proteolytic activity, and direct biological activity of potent molecules (e.g., cytokines); examples of all of these are documented in the literature. [1][2][3][4][5] Currently, immunoassays are almost universally used to monitor total residual HCP levels in the industry (the use of Fourier transform mid infrared spectroscopy has also recently been reported 6 ), but whether specific, critical HCPs should be individually measured is an open question. 7,8 Monoclonal antibodies (mAbs) constitute a substantial portion of the biopharmaceutical industry's current biotherapeutics portfolio, and downstream purification of mAbs has evolved into platform processes that are highly similar across the pharmaceutical industry.…”
Section: Introductionmentioning
confidence: 99%
“…Potential risks associated with specific HPCs may include immunogenicity, adjuvant activity, proteolytic activity, and direct biological activity of potent molecules (e.g., cytokines); examples of all of these are documented in the literature. [1][2][3][4][5] Currently, immunoassays are almost universally used to monitor total residual HCP levels in the industry (the use of Fourier transform mid infrared spectroscopy has also recently been reported 6 ), but whether specific, critical HCPs should be individually measured is an open question. 7,8 Monoclonal antibodies (mAbs) constitute a substantial portion of the biopharmaceutical industry's current biotherapeutics portfolio, and downstream purification of mAbs has evolved into platform processes that are highly similar across the pharmaceutical industry.…”
Section: Introductionmentioning
confidence: 99%
“…The sensitivity of the model may also depend on the covered concentration range. The here presented models cover a relatively small concentration range between 700 to approximately 2000 ng ml −1 of HCPs, whereas previously reported models cover concentration ranges factor > 40 larger and exhibit limits of quantification of around 2000 ng mL −1 and higher [16]. Another parameter to be monitored was the amount of mAb aggr .…”
Section: Resultsmentioning
confidence: 95%
“…protein A chromatography which typically yields a purity of >98%, with residual HCP levels between hundreds and several thousands of ppm [22]. Additional better-suited applications include upcoming alternative means of protein purification such as precipitation, resulting in elevated HCP profiles [16,17]. It may also be useful for determining HCP levels in samples derived from chromatography runs in case the expected HCP levels are higher and meet the required amounts for IR-based quantification.…”
Section: Resultsmentioning
confidence: 98%
See 2 more Smart Citations